American Gastroenterological Association Institute technical review on the role of elastography in chronic liver diseases

S Singh, AJ Muir, DT Dieterich, YT Falck-Ytter - Gastroenterology, 2017 - Elsevier
Chronic liver diseases (CLDs), due to chronic hepatitis C; hepatitis B; nonalcoholic fatty liver
diseases (NAFLD); and alcoholic liver disease, are a leading cause of morbidity and …

Imaging-based noninvasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline

A Duarte-Rojo, B Taouli, DH Leung, D Levine… - Hepatology, 2025 - journals.lww.com
Conclusions: LSM from TE, shear wave elastography, and MRE shows acceptable to
outstanding accuracy for the detection of liver fibrosis across various liver disease etiologies …

AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis

RK Sterling, A Duarte-Rojo, K Patel, SK Asrani… - Hepatology, 2025 - journals.lww.com
Chronic liver disease (CLD) is associated with approximately two million annual deaths
worldwide and is an enormous health burden.[1, 2] The majority of liver-related outcomes …

[PDF][PDF] Performance characteristics of vibration‐controlled transient elastography for evaluation of nonalcoholic fatty liver disease

R Vuppalanchi, MS Siddiqui, ML Van Natta… - …, 2018 - Wiley Online Library
Vibration‐controlled transient elastography estimates liver stiffness measurement (LSM) and
controlled attenuation parameter (CAP), which are noninvasive assessments of hepatic …

[HTML][HTML] EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis

European Association for the Study of the Liver - Journal of hepatology, 2015 - Elsevier
Liver fibrosis is part of the structural and functional alterations in most chronic liver diseases.
It is one of the main prognostic factors as the amount of fibrosis is correlated with the risk of …

Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline

K Patel, SK Asrani, MI Fiel, D Levine, DH Leung… - Hepatology, 2025 - journals.lww.com
Hepatology AASLD Publications Hepatology Liver Transplantation Hepatology
Communications Clinical Liver Disease Log in or Register Subscribe to journalSubscribe Get …

Magnetic resonance elastography of liver: current update

S Hoodeshenas, M Yin… - Topics in Magnetic …, 2018 - journals.lww.com
The first clinical application of magnetic resonance elastography (MRE) was in the
evaluation of chronic liver disease (CLD) for detection and staging of liver fibrosis. In the …

Non-invasive markers of liver fibrosis: adjuncts or alternatives to liver biopsy?

JL Chin, M Pavlides, A Moolla, JD Ryan - Frontiers in pharmacology, 2016 - frontiersin.org
Liver fibrosis reflects sustained liver injury often from multiple, simultaneous factors. Whilst
the presence of mild fibrosis on biopsy can be a reassuring finding, the identification of …

A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis

J Boursier, V de Ledinghen, V Leroy, R Anty… - Journal of …, 2017 - Elsevier
Background & Aims Chronic liver diseases (CLD) are common, and are therefore mainly
managed by non-hepatologists. These physicians lack access to the best non-invasive tests …

Diagnostic accuracy of noninvasive markers of steatosis, NASH, and liver fibrosis in HIV-monoinfected individuals at risk of nonalcoholic fatty liver disease (NAFLD) …

M Lemoine, L Assoumou, S De Wit… - JAIDS Journal of …, 2019 - journals.lww.com
Background: HIV-monoinfected individuals are at high risk of nonalcoholic fatty liver
disease. Noninvasive tests of steatosis, nonalcoholic steatohepatitis (NASH), and fibrosis …